Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil

被引:16
|
作者
Castilho, E. C. D. [1 ]
Reis, A. M. M. [2 ]
Borges, T. L. [1 ]
Siqueira, L. D. C. [3 ]
Miasso, A. I. [1 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Nursing Sch, Psychiat Nursing & Human Sci Dept, Ribeirao Preto, SP, Brazil
[2] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[3] Grande Dourados Univ Hosp, Dourados, MS, Brazil
关键词
aged; drug interactions; drug therapy; health of the elderly; patient safety; polypharmacy; MEDICATION RECONCILIATION; PSYCHIATRIC-PATIENTS; INAPPROPRIATE MEDICATIONS; PSYCHOTROPIC MEDICATIONS; COHORT; PREVALENCE; FLUOXETINE; ADMISSIONS; MANAGEMENT; PAROXETINE;
D O I
10.1111/jpm.12431
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Accessible Summary What is known on the subject? Older individuals constitute an increasing proportion of the population, and therefore, are the major consumers of drugs. The elderly, especially those with mental disabilities, frequently develop chronic diseases and start using numerous drugs. Drug-drug interactions (DDIs) are a major clinical problem in the elderly population, and previous studies have focused only on antidepressants and others types of drugs used to treat mental health conditions. What this article adds to existing knowledge? This study shows that in hospitalized elderly patients with mental disorders (aged 60-69years), polypharmacy (5 drugs) and the use of drugs that act on the cardiovascular, respiratory and nervous systems can lead to potential drug-drug interactions. Moreover, it was reported that the prevalence of drug-drug interactions in elderly patients with mental disorders was high during their hospitalization in a public hospital in Brazil. What are the implications for practice? Nurses should know the factors associated with drug-drug interactions in hospitalized elderly patients with mental disorders to choose appropriate strategies for avoiding treatment failure and adverse events in patients. Abstract Introduction Despite the impact on patient safety and the fact that prevalence is higher in older patients, previous research did not analyse drug-drug interactions (DDIs) in view of nursing care of elderly psychiatric patients. Aim To identify potential drug-drug interactions and polypharmacy in prescriptions of aged inpatients with psychiatric disorders and analyse associated factors. Methods In this retrospective cross-sectional study, we analysed the medical records of institutionalized patients diagnosed with psychiatric disorders (n=94), aged >60years, and prescribed multiple medications. Drug prescriptions were checked at admission, midway through and the last prescription. Factors associated with DDI occurrence were assessed using multivariable logistic regression analysis. Results A DDI prevalence potential of 67.0%, 74.5% and 80.8% occurred in patients at admission, midway through hospitalization and the last prescription, respectively. Most of the prescribed drugs were nervous system agents. A high percentage of serious and contraindicated potential DDIs occurred. Age between 60 and 69years, use of cardiovascular and respiratory system drugs, and the number of medications contributed significantly to DDI. Implications for mental health nursing Knowledge on the factors associated with DDIs in patients with mental disorders can contribute to the improvement of effectiveness and safety of nursing care.
引用
收藏
页码:3 / 13
页数:11
相关论文
共 50 条
  • [41] The relationship between potential drug-drug interactions and mortality rate of elderly hospitalized patients
    Rosas-Carrasco, Oscar
    Garcia-Pena, Carmen
    Sanchez-Garcia, Sergio
    Vargas-Alarcon, Gilberto
    Miguel Gutierrez-Robledo, Luis
    Juarez-Cedillo, Teresa
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2011, 63 (06): : 564 - 573
  • [42] Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
    Marwan Sheikh-Taha
    Myriam Asmar
    BMC Geriatrics, 21
  • [43] The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy
    Guven, Deniz C.
    Kavgaci, Gozde
    Aktepe, Oktay H.
    Yildirim, Hasan C.
    Sahin, Taha K.
    Aksoy, Sercan
    Erman, Mustafa
    Kilickap, Saadettin
    Yalcin, Suayib
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (04) : 785 - 793
  • [44] Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
    Sheikh-Taha, Marwan
    Asmar, Myriam
    BMC GERIATRICS, 2021, 21 (01)
  • [45] Characterization of potential drug-drug interactions in patients hospitalized in the intensive care unit of a tertiary hospital in Bogota
    Hernandez, Marcela
    Tribino, Gabriel
    Bustamante, Carlos
    BIOMEDICA, 2018, 38 (03): : 407 - 416
  • [46] "Potential" Drug-Drug Interactions and the PICU: Should We Worry About ICU Polypharmacy?
    Bhatt-Mehta, Varsha
    PEDIATRIC CRITICAL CARE MEDICINE, 2016, 17 (05) : 470 - 472
  • [47] Polypharmacy and potential drug-drug interactions among Greenland's care home residents
    Albertsen, Nadja
    Sommer, Tine Gjedde
    Olsen, Thomas Mikkel
    Prischl, Anna
    Kallerup, Hans
    Andersen, Stig
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2022, 13
  • [48] Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?
    Noor, Sidra
    Ismail, Mohammad
    Ali, Zahid
    BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (1)
  • [49] Evaluation of potential drug-drug interactions in cancer patients at a tertiary care hospital in Pakistan
    Choudary, Nida Ashraf
    Khan, Asad
    Wahid, Abdul
    Abubakar, Muhammad
    Atif, Muhammad
    Ahmad, Nafees
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (03) : 618 - 626
  • [50] Potential drug-drug interactions among prescriptions for elderly patients in primary health care
    Goren, Zafer
    Demirkapu, Mahluga J.
    Akpinar Acet, Gokce
    Cali, Sanda
    Gulcebi Idriz Oglu, Medine
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2017, 47 (01) : 47 - 54